Literature DB >> 18222012

Methylenetetrahydrofolate reductase 677 T allele protects against persistent HBV infection in West Africa.

Jean-Pierre Bronowicki1, Idrissia Abdelmouttaleb, Laurent Peyrin-Biroulet, Véronique Venard, Hacène Khiri, Nicodème Chabi, Emile K Amouzou, Hélène Barraud, Philippe Halfon, Ambaliou Sanni, Marc-André Bigard, Alain Le Faou, Jean-Louis Guéant.   

Abstract

BACKGROUND/AIMS: Homocysteine metabolism is linked to DNA methylation, a mechanism potentially involved in the course of hepatitis B virus (HBV) infection. We evaluated the association of determinants of homocysteine metabolism with the outcome of HBV infection.
METHODS: Four hundred and fifty-five healthy adults from Togo and Benin were tested for HBV serologic markers, HLA DR alleles, folate, vitamin B12, methylenetetrahydrofolate reductase (MTHFR) 677 C-->T, 1298 A-->C and methionine synthase 2756 A-->G polymorphisms.
RESULTS: Seventy-eight percent of the study population was anti-HBc positive. Among them, 202 (56.9%) were anti-HBs positive and 58 (16.3%) were HBsAg positive. After stepwise logistic regression, the MTHFR 677 T allele was independently associated with persistence of detectable anti-HBs antibodies (OR: 2.47; 95% CI: 1.29-4.71; p=0.006). The mean HBV DNA level was significantly lower in HBsAg positive subjects carrying the 677 T allele than in those with the 677 CC genotype (1000+/-1406 vs. 2,400,000+/-214,000 copies/ml, p=0.005). Beninese origin and HLA-DRB1*09 allele were the other determinants independently associated with favorable outcome of HBV infection.
CONCLUSIONS: The methylenetetrahydrofolate reductase 677 T allele seems to protect against chronic HBV infection in young African adults.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18222012     DOI: 10.1016/j.jhep.2007.11.017

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  2 in total

1.  The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D).

Authors:  C L Raison; A H Miller
Journal:  Mol Psychiatry       Date:  2012-01-31       Impact factor: 15.992

2.  Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-α antagonists.

Authors:  Valentina Germano; Maria Sofia Cattaruzza; John Osborn; Aurora Tarantino; Roberta Di Rosa; Simonetta Salemi; Raffaele D'Amelio
Journal:  J Transl Med       Date:  2014-03-22       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.